Macquarie believes that concerns over BUSYMING's recent franchisee subsidies are exaggerated, as the policies have strict application standards. Although they lowered their profit forecasts for FY2026 and FY2027 by 3% each and reduced the target price from HKD588 to HKD572, they maintain an Outperform rating.
